Eden Research plc (LSE:EDEN), a UK-listed developer of sustainable biopesticides and microencapsulation technologies, has completed a series of fundraising initiatives, bringing total proceeds to approximately £10.8 million. The capital was raised through a combination of a firm placing, subscription, retail offer, and conditional placing.
Following a second admission expected around 13 April 2026, 190 million new shares will be admitted to trading on AIM, increasing the company’s total issued share capital to 803,362,994 shares. This expansion strengthens Eden’s balance sheet while also updating its shareholder voting framework in line with FCA transparency requirements.
The additional funding is intended to support the company’s growth plans, including further commercial rollout and regulatory advancement of its sustainable crop protection products. The transaction, led by Cavendish Capital Markets and Oberon Investments as joint bookrunners, highlights continued investor interest in environmentally focused agricultural technologies, particularly as global regulations tighten around traditional pesticides and microplastics.
Despite this progress, Eden’s outlook remains mixed. The company continues to report losses and negative operating and free cash flow, even as revenues grow and the balance sheet remains relatively stable. On the technical side, the shares have shown strong upward momentum, trading above key moving averages, although overbought conditions suggest the potential for near-term volatility. Valuation remains difficult to assess given the absence of profitability and dividend data.
More about Eden Research
Eden Research plc is a UK-based developer of sustainable biopesticide and biocontrol solutions for agriculture, animal health, and consumer markets. Its portfolio includes products such as Mevalone (a fungicide), Cedroz (a nematicide), and Ecovelex (a bird-repellent seed treatment), all built on its proprietary plastic-free Sustaine encapsulation technology. Focused on high-value crops and environmentally driven markets, the company aims to replace conventional chemical pesticides with plant-based alternatives that align with evolving regulatory and sustainability demands.
Leave a Reply